tirzepatide clinicaltrials gov Early‐Onset Obesity and Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials - Gourgari - 2025 - Obesity FDA Approves Tirzepatide, A Potential

"Because this was an observational study in a specific clinical population, randomized clinical trials are needed before GLP-1 medications can be recommended for treating addiction." The researchers plan to continue investigating the relationship between GLP-1 therapies and substance use behaviors through prospective studies that follow patients after they begin treatment, according to the study

This calculation becomes important when designing protocols

Protocols designed around daily IM injections because 'that's how we've always done it,' despite the fact that the study endpoint measures 24-hour lipid flux and would benefit more from SubQ's flatter curve

| 06.08.26 | 9 min read